N/A
N=70
Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound
Breast Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02819362 ↗Enrolled (actual)
70
Serious AEs
—
Results posted
Oct 2025
Primary outcome: Primary: The Negative Predictive Value (PVV) of MRI
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- MRI (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Institut Bergonié
- Primary completion
- Dec 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Negative Predictive Value (PVV) of MRI |
— | — |
Summary
Benefit of MRI in pathological nipple discharge.
Eligibility Criteria
Inclusion Criteria
- Single pore nipple discharge neither green nor milky.
- Mammography (at least 2 shots, +/- centred on retro-areal) normal.
- Initial ultrasound: normal.
- Age over 18 years
- Female
- Patient affiliated to the social security scheme.
- Patient information and informed consent signed and dated
Exclusion Criteria
Physiological milky or green discharge
Data sourced from ClinicalTrials.gov (NCT02819362). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.